Related references
Note: Only part of the references are listed.Intranasal delivery of polymer-anchored lipid nanoconstructs of artemether-lumefantrine in Plasmodium berghei ANKA murine model
Ripandeep Kaur et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)
Efficient Treatment of Experimental Cerebral Malaria by an Artemisone-SMEDDS System: Impact of Application Route and Dosing Frequency
Johanna Zech et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria
Kesley A. O. Pontes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
Intranasal artesunate-loaded nanostructured lipid carriers: A convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria
Chinazom Precious Agbo et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Imatinib augments standard malaria combination therapy without added toxicity
Huynh Dinh Chien et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Molecular targets in cerebral malaria for developing novel therapeutic strategies
Ravisankar Vanka et al.
BRAIN RESEARCH BULLETIN (2020)
Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
Jacob Golenser et al.
FRONTIERS IN PHARMACOLOGY (2020)
Pathophysiology and neurologic sequelae of cerebral malaria
Nicoline Schiess et al.
MALARIA JOURNAL (2020)
Promising nanomaterials in the fight against malaria
Livia Neves Borgheti-Cardoso et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
New leads for drug repurposing against malaria
Nila Madassary Pazhayam et al.
DRUG DISCOVERY TODAY (2019)
Neurodevelopmental Impairments 1 Year After Cerebral Malaria
John T. Langfitt et al.
PEDIATRICS (2019)
Blood-Brain Barrier in Cerebral Malaria: Pathogenesis and Therapeutic Intervention
Gopala Nishanth et al.
TRENDS IN PARASITOLOGY (2019)
Human cerebral malaria: 2019 mini review
F. Bruneel
REVUE NEUROLOGIQUE (2019)
Oral administration of Coenzyme Q10 protects mice against oxidative stress and neuro-inflammation during experimental cerebral malaria
James N. Nyariki et al.
PARASITOLOGY INTERNATIONAL (2019)
Fenozyme Protects the Integrity of the Blood-Brain Barrier against Experimental Cerebral Malaria
Shuai Zhao et al.
NANO LETTERS (2019)
Cerebral malaria is associated with differential cytoadherence to brain endothelial cells
Janet Storm et al.
EMBO MOLECULAR MEDICINE (2019)
Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties
Aissata Camara et al.
MALARIA JOURNAL (2019)
Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria
Adriana A. Marin Rodriguez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers
Ravisankar Vanka et al.
JOURNAL OF MICROENCAPSULATION (2018)
Long circulatory liposomal maduramicin inhibits the growth of Plasmodium falciparum blood stages in culture and cures murine models of experimental malaria
Mohsin Raza et al.
NANOSCALE (2018)
α-Tocopheryl succinate-suppressed development of cerebral malaria in mice
Aiko Kume et al.
PARASITOLOGY RESEARCH (2018)
Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators
Kim E. Schmidt et al.
PLOS ONE (2018)
Ethanolic extract of the fungus Trichoderma stromaticum decreases inflammation and ameliorates experimental cerebral malaria in C57BL/6 mice
Yusmaris Cariaco et al.
SCIENTIFIC REPORTS (2018)
Oral administration of vitamin D and importance in prevention of cerebral malaria
Bo Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
Peng Kai Ong et al.
SCIENTIFIC REPORTS (2018)
Polymeric Nanocarriers for the Delivery of Antimalarials
Zandile Mhlwatika et al.
MOLECULES (2018)
Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria
Yunting Du et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria
Valerie M. Crowley et al.
MALARIA JOURNAL (2017)
A single rapamycin dose protects against late-stage experimental cerebral malaria via modulation of host immunity, endothelial activation and parasite sequestration
Pedro Mejia et al.
MALARIA JOURNAL (2017)
Controlled release of artemisone for the treatment of experimental cerebral malaria
Jacob Golenser et al.
PARASITES & VECTORS (2017)
Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria
Chaitanya Dende et al.
SCIENTIFIC REPORTS (2017)
Protein Tyrosine Phosphatase Inhibition Prevents Experimental Cerebral Malaria by Precluding CXCR3 Expression on T Cells
Kristin M. Van Den Ham et al.
SCIENTIFIC REPORTS (2017)
Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection
Thittayil Suresh Apoorv et al.
CYTOKINE (2017)
Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria
Priyanka Prabhu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
Claudia Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria
Chaitanya Dende et al.
SCIENTIFIC REPORTS (2015)
Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches
Praveen K. Sahu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2015)
Optimization of artemether-loaded NLC for intranasal delivery using central composite design
Kunal Jain et al.
DRUG DELIVERY (2015)
Potential Efficacy of Citicoline as Adjunct Therapy in Treatment of Cerebral Malaria
Fatima El-Assaad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Vitamin D Inhibits the Occurrence of Experimental Cerebral Malaria in Mice by Suppressing the Host Inflammatory Response
Xiyue He et al.
JOURNAL OF IMMUNOLOGY (2014)
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
Wesley Solomon et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Anne Marijon et al.
MALARIA JOURNAL (2014)
Reduction of Experimental Cerebral Malaria and Its Related Proinflammatory Responses by the Novel Liposome-Based β-Methasone Nanodrug
Jintao Guo et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?
Manuela Polimeni et al.
FLUIDS AND BARRIERS OF THE CNS (2014)
Transdermal Glyceryl Trinitrate as an Effective Adjunctive Treatment with Artemether for Late-Stage Experimental Cerebral Malaria
Pamela Orjuela-Sanchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Azadirachta indica ethanolic extract protects neurons from apoptosis and mitigates brain swelling in experimental cerebral malaria
Selma Bedri et al.
MALARIA JOURNAL (2013)
Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model
Jerome Dormoi et al.
MALARIA JOURNAL (2013)
Malaria biology and disease pathogenesis: insights for new treatments
Louis H. Miller et al.
NATURE MEDICINE (2013)
Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria
Judith H. Waknine-Grinberg et al.
PLOS ONE (2013)
Human cerebral malaria and Plasmodium falciparum genotypes in Malawi
Danny A. Milner et al.
MALARIA JOURNAL (2012)
Statins Decrease Neuroinflammation and Prevent Cognitive Impairment after Cerebral Malaria
Patricia A. Reis et al.
PLOS PATHOGENS (2012)
Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy
S. Balachandar et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Peroxisome proliferator-activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis
Saravanan Kanakasabai et al.
IMMUNOLOGY (2010)
Use of Peroxisome Proliferator-Activated Receptor γ Agonists as Adjunctive Treatment for Plasmodium falciparum Malaria: A Randomized, Double-Blind, Placebo-Controlled Trial
Andrea K. Boggild et al.
CLINICAL INFECTIOUS DISEASES (2009)
Rosiglitazone Modulates the Innate Immune Response to Plasmodium falciparum Infection and Improves Outcome in Experimental Cerebral Malaria
Lena Serghides et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria
Climent Casals-Pascual et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain
Yashwant Gupta et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Tumor necrosis factor α in the pathogenesis of cerebral malaria
F Gimenez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Towards a blood-stage vaccine for malaria: Are we following all the leads?
MF Good
NATURE REVIEWS IMMUNOLOGY (2001)
Share Paper
